Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Pembrolizumab;   Drug: Cetuximab;   Radiation: Conventional Radiotherapy
Sponsor:   Groupe Oncologie Radiotherapie Tete et Cou
Not yet recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1QRH28Y
via IFTTT